Back to Blog
Featured image for MeducationAI blog article: AI in Hematology Oncology Fellowship Training: A Practical Framework for Program Directors

April 12, 2026

16 min read

AI in Hematology Oncology Fellowship Training: A Practical Framework for Program Directors


Written by Dr. Roupen Odabashian MD, FRCPC, FASC

Hematologist Oncologist | Founder, MeducationAI | Updated April 2026

Summarize this article with: ChatGPT | Claude | Perplexity | Google AI


AI in hematology oncology fellowship training is no longer a futuristic concept — it is a practical necessity for programs that want to keep pace with the specialty. As a hematologist oncologist who uses AI daily in both clinical practice and fellowship education, I can tell you that the volume of new therapies, molecular targets, and guideline updates has outpaced what any fellowship curriculum can deliver through traditional methods alone. AI offers a way to close that gap, not by replacing the attending physician or the bedside experience, but by giving fellows more repetitions, faster feedback, and structured exposure to the breadth of cases they need before they practice independently. In this article, I will walk you through a practical framework for using AI across four high-impact domains in hematology oncology fellowship training: clinical case simulations, practice question generation, literature synthesis, and tumor board preparation.

TL;DR

  • AI in hematology oncology fellowship training addresses the gap between rapidly evolving guidelines and the limitations of traditional curricula, giving fellows structured exposure to rare and high-yield cases they might otherwise miss during rotations.

  • The four highest-impact applications are AI-powered clinical case simulations, guideline-aligned practice question generation, literature review synthesis, and tumor board preparation — each backed by emerging evidence from peer-reviewed studies.

  • Faculty oversight is non-negotiable: every AI-generated case, question, or summary must be reviewed by a content expert before reaching learners, and AI should never be used directly in patient care without verification.

  • Programs should implement AI in phases — starting with a needs assessment and a single pilot domain (practice questions work well), then expanding to case simulations and full curricular integration over 12 to 18 months.

  • Purpose-built medical education platforms like MeducationAI offer advantages over general-purpose chatbots because they ground content in current clinical guidelines and include built-in faculty review workflows.

Why Does Hematology Oncology Fellowship Training Need AI Now?

Hematology oncology fellowship programs need AI integration now because the specialty is evolving faster than traditional curricula can keep pace. Consider the numbers: there are over 80 FDA-approved targeted therapies in oncology, NCCN guidelines are updated multiple times per year across dozens of disease sites, and molecular testing has become central to treatment selection in nearly every malignancy. A fellow who started training two years ago is graduating into a fundamentally different practice landscape.

The 2025 ASCO workforce survey found that a significant majority of surveyed hematology oncology faculty believe AI should be incorporated into fellowship training. This is not a fringe opinion — it reflects a growing consensus that we need new tools to prepare the next generation of oncologists for the complexity of modern practice.

The AAMC's 2025 Principles for Responsible AI Use in Medical Education explicitly call on training programs to develop structured approaches to AI integration, including faculty development and learner competency frameworks. This is no longer about whether to adopt AI in fellowship training — it is about how to do it thoughtfully.

![AI Integration in Fellowship Training](images/article-03-integration-diagram.png)

What Are the Four High-Impact Applications of AI in Hematology Oncology Fellowship Training?

The four domains where AI delivers the greatest educational value in hematology oncology fellowship training are clinical case simulations, practice question generation, literature synthesis, and tumor board preparation. Based on my experience and the emerging literature, these applications address the most common gaps in traditional fellowship curricula while preserving the physician-led mentorship that defines high-quality training.

How Do AI-Powered Clinical Case Simulations Improve Fellow Training?

AI-powered clinical case simulations improve fellow training by generating realistic, branching patient encounters that expose learners to rare or complex presentations they might not see on their clinical rotations. In hematology, a fellow at one institution might see dozens of AML cases but only one or two cases of hairy cell leukemia during their entire training. In oncology, exposure to rare tumor types or unusual treatment complications depends entirely on the patient population at your center.

AI-powered clinical case simulations solve this problem by generating realistic patient encounters that adapt to the fellow's clinical decisions in real time. If a fellow orders the wrong initial workup for a suspected TTP case, the simulation can redirect with feedback explaining why an ADAMTS13 activity level is critical before starting plasma exchange. If they get stuck, the system provides guided hints rather than simply giving away the answer. The goal is not to replace clinical rotations but to supplement them, ensuring every fellow gets exposure to the full breadth of hematologic and oncologic presentations regardless of their rotation site.

This is exactly the kind of capability we have been building at MeducationAI. Our AI-driven clinical case simulations are grounded in current guidelines, reviewed by subspecialty faculty, and designed to test the kind of clinical reasoning that matters for both board exams and real patient care.

A 2025 study in the Journal of CME confirmed that clinical simulation with ChatGPT-style models represents a meaningful advance in medical education, particularly for specialties where case variety is critical to competency.

How Can AI Generate Board-Aligned Practice Questions for Hematology Oncology?

AI can generate high-quality, guideline-aligned practice questions for hematology oncology board preparation by being prompted with specific learning objectives, NCCN guideline versions, and Bloom's taxonomy levels to ensure clinical reasoning rather than rote recall. Board preparation in hematology oncology is a massive undertaking — the breadth of content spanning malignant hematology, benign hematology, medical oncology, and supportive care is staggering. Traditional question banks are static, expensive to update, and cannot keep pace with the speed at which guidelines change.

A 2026 study in Scientific Reports evaluated the performance of ChatGPT, Perplexity, and DeepSeek in generating hematology multiple-choice questions and found that AI-generated questions can meet acceptable standards of clinical accuracy and cognitive complexity when given clear prompting frameworks aligned to specific learning objectives and Bloom's taxonomy levels.

Attendings and Faculty can use AI to generate case vignettes that test fellows on the most current NCCN guidelines. For example, I can prompt an AI system to create a question about frontline management of DLBCL in an elderly patient with cardiac comorbidities, specifying that the question should test application-level reasoning rather than simple recall. The AI generates the stem, distractors, and a detailed explanation with guideline citations baesd on the ground truth that the attending or the faculty see appropriate. I review and edit before it reaches the fellow, but the time savings are enormous; what used to take an hour now takes ten minutes.

The key safeguard here is faculty oversight. AI-generated questions must be reviewed by a content expert before they are used in any formative or summative assessment. The AAMC principles make this clear: AI should augment, not replace, the educator's judgment. If you are exploring how to build a comprehensive oncology board review strategy, combining AI-generated questions with traditional resources can maximize both coverage and efficiency.

How Does AI Assist With Literature Review and Evidence Synthesis?

AI assists with literature review by rapidly identifying, summarizing, and cross-referencing relevant publications from major oncology journals, allowing fellows to prepare for journal club and tumor boards in a fraction of the time while still developing critical appraisal skills. Hematology oncology fellows are expected to present at journal club, prepare for tumor boards, and stay current with a literature base that publishes thousands of new papers each year. AI tools can dramatically accelerate this process.

When I work with fellows on their journal club presentations, I encourage them to use AI to identify key findings, summarize methodology, and flag limitations and have a general idea of the paper before reading it then read the full paper. The fellow then critically evaluates the AI's summary against the actual paper, identifies what the AI got right, what it oversimplified, and what it missed entirely.

This approach accomplishes two things simultaneously. It teaches fellows to use AI as a clinical tool while simultaneously training them in the critical evaluation of AI-generated content. Both skills will be essential in their careers. The Lancet Digital Health viewpoint on AI in medical training emphasizes that teaching trainees to evaluate AI outputs critically is as important as the content knowledge itself.

The risk of hallucination is real, and I address it directly in the section below. But the solution is not to avoid AI, it is to build verification workflows into the educational process itself.

Beyond summarising and identifying key findings, AI can help with tedious tasks. At MeDucation AI, we built a tool to help fellows build their lectures so they can spend more time reading the paper rather than copying and pasting and creating PowerPoint slides.

How Can AI Enhance Tumor Board Preparation for Fellows?

AI enhances tumor board preparation by helping fellows compile relevant staging data, generate differential diagnoses, review applicable NCCN guidelines, and identify relevant clinical trial options, all before the presentation, so the fellow arrives better prepared for multidisciplinary discussion. Tumor board is the cornerstone of multidisciplinary cancer care, and it is one of the most high-stakes educational experiences in fellowship training. Fellows are expected to present cases concisely, know the relevant literature, and be prepared for questions from surgical oncology, radiation oncology, pathology, and radiology.

AI can help fellows prepare more efficiently and more thoroughly. Before a tumor board presentation, a fellow can use AI to review the current NCCN guidelines for the specific disease and stage, identify relevant clinical trials for which the patient might be eligible, summarize key studies that inform the treatment decision, and anticipate questions that other specialties might raise.

I have seen fellows use this approach to transform their tumor board presentations from simple case recitations into thoughtful, evidence-driven discussions that impress attendings and contribute meaningfully to patient care decisions. A 2025 study in Communications Medicine found that LLM-based simulated patient systems offer significant potential for transforming how trainees prepare for complex clinical scenarios.

Even during tumour board, tools like Doximity GPT, OpenEvidence, Heidi's AI clinical decision support, and Up-to-date AI clinical decision support help in finding relevant articles and phase one and phase two trials that are recent and usually not included in the guidelines; however, they can change the trajectory of patient management. AI tools can personalise cancer care by streamlining the finding of valuable data like this

How Do You Build an AI Clinical Case for Hematology Fellowship Training?

Building an AI clinical case for hematology fellowship training takes about 30 minutes of faculty time and follows five steps: defining the learning objective, providing clinical context to our Meducation AI clinical MCQ builder or interactive case generator, generating the interactive case, building in decision points with feedback, and releasing the case to the learner. This example uses the type of workflow we have developed at MeducationAI, but the principles apply regardless of the specific tool you use.

Not all MCQ's and created equally! At MeducationAI, all our tools are built after reviewing literature and following best practises to improve collaboration between AI agents, and not a single LLM, whether it is a multiple choice question building or a clinical case simulation

Step 1: Define the Learning Objective

I want fellows to recognize thrombotic thrombocytopenic purpura (TTP) in a patient presenting with thrombocytopenia and microangiopathic hemolytic anemia, and to initiate appropriate emergent management.

Step 2: Provide Clinical Context to the AI

I provide MeDucation AI interactive case builder with a review article or a guideline paper.

Step 3: Generate the Interactive Case

The AI creates a simulated patient encounter where the fellow or the student must take the correct diagnostic stepts (including ADAMTS13 activity), interpret results, and initiate management. The case unfolds in real time based on the fellow's decisions. The checkpoints of the case are predetermined by the attending or the faculty

Step 4: Faculty Review and Refinement

I review the generated case for clinical accuracy, ensure the management aligns with current ASH guidelines, and adjust difficulty based on the fellow's training level. A PGY4 fellow should be expected to manage this independently. A PGY5 fellow should additionally be asked about rituximab and caplacizumab.

This entire process takes about 2-5 minutes of my time, compared to several hours for building a traditional simulation case from scratch. More importantly, the case is interactive, adaptive, and can be reused across multiple fellows with variation in presentation.

What Are the Key Concerns About AI in Hematology Oncology Education?

Why Is AI Hallucination Particularly Dangerous in Oncology?

AI hallucination is particularly dangerous in oncology because a fabricated drug recommendation, incorrect dosing regimen, or inaccurate staging criterion can directly harm patients, making robust verification workflows essential in any AI-integrated training program. The most common concern I hear from program directors about AI in hem/onc education is hallucination. And they are right to be concerned.

At MeDucation AI, our AI system never decides on its own. Every decision is supervised by an expert, whether it's generating our question bank or creating simulated cases

The Frontiers in Education review on AI in residency training emphasizes that the risk of AI-generated misinformation is most acute in clinical specialties where errors have immediate patient safety implications. Hematology oncology sits squarely in this category.

My approach to this problem is threefold:

1. Never use AI output directly in patient care without verification. This is a non-negotiable rule in our program. AI is a preparation and learning tool, not a clinical decision-making tool.

2. Build verification into the educational workflow. When fellows use AI-generated content (case simulations, practice questions, literature summaries), they are expected to cross-reference against primary sources. This is itself a critical clinical skill.

3. Use AI systems designed for medical education, not general-purpose chatbots. A platform that is purpose-built for clinical case simulation with guideline grounding and faculty review, like what we are building at MeducationAI, provides fundamentally different safety guardrails than asking a general-purpose LLM to generate a clinical case.

How Do You Ensure Guideline Accuracy and Currency?

You ensure guideline accuracy by using AI platforms that are regularly updated against current NCCN and ASH guidelines, combined with mandatory faculty review cycles timed to major guideline releases. NCCN guidelines are updated multiple times per year. A practice question generated six months ago may already reflect outdated management for certain cancers.

The JMIR 2026 review on AI's transformative potential in medical education notes that the most effective AI-integrated curricula build in regular content auditing cycles where faculty review AI-generated materials against the most current guideline versions. This is not a one-time setup — it is an ongoing quality assurance process.

What Is the Implementation Roadmap for AI in Fellowship Programs?

The implementation roadmap for AI in hematology oncology fellowship training follows four phases over approximately 18 months, starting with foundation and needs assessment, moving through a focused pilot, then expanding to multiple domains, and finally achieving full curricular integration. If you are a hem/onc fellowship program director looking to integrate AI into your curriculum, here is a phased approach that I recommend based on what has worked in our program and what the literature supports.

Phase 1: Foundation (Months 1 to 3)

  • Conduct a needs assessment: where are the biggest gaps in your fellows' clinical exposure?

  • Identify 2 to 3 faculty champions who are comfortable with AI tools

  • Establish a program-level policy on AI use in education (the AAMC principles are an excellent starting point)

  • Select one domain to pilot (I recommend starting with AI-generated practice questions, as this has the lowest barrier to entry and the most immediate value for fellows preparing for boards)

Phase 2: Pilot (Months 4 to 6)

  • Launch your pilot domain with a small cohort of fellows

  • Implement a faculty review workflow for all AI-generated content

  • Collect fellow feedback on educational value and usability

  • Track any instances of AI inaccuracy to calibrate your review process

Phase 3: Expansion (Months 7 to 12)

  • Add a second domain (clinical case simulations are the natural next step)

  • Integrate AI activities into existing curricular structures (didactic sessions, board review, journal club)

  • Begin using AI-generated cases for formative assessment

  • Present your experience at a regional or national meeting (ASH, ASCO, or your ACGME program review)

Phase 4: Integration (Year 2 and Beyond)

  • AI tools are embedded across all four domains

  • Fellows are assessed on AI literacy as a core competency

  • Program contributes to the growing evidence base on AI in fellowship education

  • Curriculum is updated annually to reflect new AI capabilities and guidelines

The ASH Clinical News feature on AI in medical education provides additional examples of programs that have successfully integrated AI tools into hematology training, and the lessons they have learned along the way. For a broader look at the research evidence supporting these approaches, see our analysis of what the research says about AI in medical education.

Frequently Asked Questions

Will AI Replace the Clinical Experience Fellows Get From Seeing Real Patients?

No. AI simulations supplement clinical rotations; they do not replace them. The goal is to ensure that every fellow encounters the full spectrum of hematologic and oncologic diagnoses during training, including rare presentations that may not appear at their institution. AI fills gaps in clinical exposure while the bedside experience remains the foundation of fellowship training.

How Do I Ensure AI-Generated Content Is Accurate for Hematology Oncology?

Faculty oversight is essential. Every AI-generated case, question, or summary should be reviewed by a board-certified hematologist oncologist before it reaches learners. Purpose-built platforms like MeducationAI include faculty review workflows and guideline grounding that general-purpose chatbots lack. Build in regular content auditing cycles timed to major NCCN and ASH guideline updates.

What AI Tools Should a Hematology Oncology Fellowship Program Use?

This depends on your goals. For clinical case simulations, purpose-built platforms designed specifically for medical education offer better safety guardrails than general-purpose chatbots. For literature review and evidence synthesis, tools like ChatGPT and Claude can be effective when paired with faculty verification. Start with a single use case and expand as your program develops AI literacy.

How Much Does It Cost to Integrate AI Into Fellowship Training?

Costs vary widely. Some AI tools are free (ChatGPT and Claude free tiers), while specialized medical education platforms involve subscription fees. The more important calculation is the time saved by faculty in content creation and the educational value gained by fellows. Many programs find that AI tools pay for themselves in faculty time savings alone within the first semester of use.

Could Fellows Use AI to Shortcut Their Learning Instead of Engaging Deeply?

This is a real concern, and it is best addressed through program culture rather than surveillance. When AI is framed as a tool for deeper learning, generating more practice cases, testing at higher cognitive levels, building clinical reasoning, fellows tend to use it constructively. Structure AI activities to require active engagement, such as clinical decision-making in simulated cases, rather than passive consumption of AI-generated answers.

Is There Evidence That AI Improves Hematology Oncology Fellowship Training Outcomes?

The evidence base is growing but still early. Studies have demonstrated that AI-powered simulations can improve clinical reasoning scores, that AI-generated questions can match expert-written questions in quality, and that trainees who use AI-assisted preparation report greater confidence in clinical decision-making. Large-scale, randomized trials specific to hem/onc fellowship training are still needed, but the early signal is strongly positive.

Ready to start your preparation?

Access the MeDucation Medical Oncology and Hematology Question Bank and begin building the systematic approach that leads to board certification success.

Get Started